Table 1.
Relationship between miR-760 and clinical data of patients.
| Factors | miR-760 relative level | P value | ||
|---|---|---|---|---|
| Low expression (n = 26) | High expression (n = 26) | |||
| Gender | 0.578 | |||
| Male (n = 28) | 13 | 15 | ||
| Female (n = 24) | 13 | 11 | ||
|
| ||||
| Age | 0.397 | |||
| ≥60 years old (n = 21) | 9 | 12 | ||
| <60 years old (n = 31) | 17 | 14 | ||
|
| ||||
| Tumor size | 0.405 | |||
| ≥5 cm (n = 27) | 12 | 15 | ||
| <5 cm (n = 25) | 14 | 11 | ||
|
| ||||
| Differentiation | 0.560 | |||
| Poorly differentiated (n = 18) | 10 | 8 | ||
| Middle+well differentiated (n = 34) | 16 | 18 | ||
|
| ||||
| Lymphatic metastasis | 0.032∗ | |||
| Metastasis (n = 15) | 11 | 4 | ||
| Nonmetastasis (n = 37) | 15 | 22 | ||
|
| ||||
| TNM staging | 0.039∗ | |||
| I+II (n = 35) | 14 | 21 | ||
| III+IV (n = 17) | 12 | 5 | ||
Note: ∗ means P < 0.05, and there were differences between groups.